Structure, attachment and entry of polyoma- and papillomaviruses  by Sapp, Martin & Day, Patricia M.
Virology 384 (2009) 400–409
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roMinireview
Structure, attachment and entry of polyoma- and papillomaviruses
Martin Sapp a,⁎, Patricia M. Day b
a Department of Microbiology and Immunology, Feist Weiller-Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, LA 71130-3932, USA
b Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA⁎ Corresponding author. Fax: +1 318 675 5764.
E-mail address: msapp1@lsuhsc.edu (M. Sapp).
0042-6822/$ – see front matter © 2009 Elsevier Inc. Al
doi:10.1016/j.virol.2008.12.022a b s t r a c ta r t i c l e i n f oArticle history: Polyoma- (PY) and Papillo
Received 2 October 2008
Accepted 8 December 2008
Available online 21 January 2009
Keywords:
Receptor
Conformational change
Endocytosis
Intracellular transportmavirus (PV) virions have remarkable structural equivalence although no
discernable sequence similarities among the capsid proteins can be detected. Their similarities include the
overall surface organization, the presence of 72 capsomeres composed of ﬁve molecules of the major capsid
proteins, VP1 and L1, respectively, the structure of the core segment of capsomeres with classical antiparallel
“jelly roll” β strands as the major feature, and the linkage of neighboring capsomeres by invading C-terminal
arms. Differences include the size of surface exposed loops that contain the dominant neutralizing epitopes,
the details of the intercapsomeric interactions, and the presence of 2 or 1 minor capsid proteins, respectively.
These differences may affect the dramatic differences observed in receptor binding and internalization
pathways utilized by these viruses, but as detailed later even structural differences cannot completely
explain receptor and pathway usage. In recent years, technical advances aiding the study of entry processes
have allowed the identiﬁcation of novel endocytic compartments and an appreciation of the links between
endocytic pathways that were previously thought to be completely separable. This review is intended to
highlight recent advances in our understanding of virus receptor interactions and their consequences for
endocytosis and intracellular trafﬁcking.
© 2009 Elsevier Inc. All rights reserved.Structure
Polyomaviruses
The outer shell of Polyomavirus (PY) virions is composed of 360
molecules of the major capsid protein VP1. They are organized into 72
capsomeres, each comprised of a pentameric VP1 assembly, centered
on the vertices of a T=7 icosahedral lattice. Twelve and sixty
capsomeres are pentavalent and hexavalent, i.e. they have ﬁve and
six nearest neighbors, respectively. The core of the capsomeres is
mainly composed of an antiparallel β-sandwich to which eight β
strands labeled B through I contribute (Liddington et al., 1991; Stehle
et al., 1996). They run roughly parallel to the 5-fold axis and are
connected by small loops. The BC, DE, FG, and HI loops face outwards
and contain the major neutralizing epitopes. The ﬁve VP1 molecules
within a capsomere are intimately associated, even displaying an
interlock of their secondary structures. The overall structure of the β-
sandwich is identical in all capsomeres.
Neighboring capsomeres are linked by invading C-terminal arms,
with each capsomere donating 5 arms and likewise receiving 5 arms
from 5 neighboring capsomeres. These interactions are stabilized by
Ca2+ ions and disulﬁde bonds. The interactions by the sequencel rights reserved.elements inserting into the neighboring capsomeres (C insert;
residues 315 to 344 in SV40 VP1) are the same for all VP1 molecules.
The A β-strand and Aα-helix of the receiving VP1molecules provide a
clamp which locks the J strand (residues 330 to 336) of the C insert
into place. This interaction is further stabilized by residues 337 to 344,
which wrap around the N-terminal arm and end at the Ca2+-binding
site (Li et al., 2003). The C-terminal arm also contains the C helix and
the C loop, which are the most variable parts and differ in the three
distinct kinds of capsomere–capsomere interactions. Three-fold
clusters link one VP1 molecule from pentavalent capsomeres to two
VP1 molecules donated by two neighboring hexavalent capsomeres
such that C-terminal arms are exchanged in a cyclical fashion. Two
different 2-fold clusters each contain two hexavalent capsomeres and
are found at the icosahedral 3-fold and 2-fold axis, respectively. In
SV40, this conﬁguration brings the highly conserved cysteine residues
at position 104 (C104) into close proximity allowing them to engage in
disulﬁde bonds. In the three-fold clusters, one C104 remains reduced
and is not involved in disulﬁde bond formation (Liddington et al.,
1991). Recent evidence suggests that the cysteine residue at position 9
(C9), which was not visible in the X-ray structure, forms C9–C9
disulﬁde bonds and also contributes to intercapsomeric crosslinks
between VP1 molecules (Schelhaas et al., 2007). Thus, essentially all
VP1 molecules in the particle are covalently connected. In murine PY
(PyV), such an extended cross-linking is not observed whichmay have
consequences for the speciﬁc requirements of viral uncoating during
entry (see below).
401MinireviewIn addition to VP1, 72 molecules of minor capsid proteins, VP2 and
VP3, are present in the viral capsid. VP2 differs from VP3 by an N-
terminal extension of 116 residues that carries a myristylation site
(Gasparovic et al., 2006; Krauzewicz et al., 1990; Sahli et al., 1993). A
highly conserved C-terminal fragment spanning residues 266 to 302
(VP2 numbering) inserts in a hairpin-like manner into the axial cavity
of capsomeres present on the inner capsomere surface. Strong
hydrophobic interactions with 3 of the 5 VP1 molecules anchor the
VP2/VP3 molecules (Chen et al., 1998). Due to high ﬂexibility no
structural information could be obtained for other parts of VP2 but it is
believed to be completely hidden inside the capsid and thus not
accessible, e.g. to antibody binding (Norkin et al., 2002).Fig. 1. Structure of HPV16 L1. (A) Structure of a L1 monomer. (B) L1 capsomere viewed along th
(C) The invading arm model reproduced with permission from (Modis et al., 2002).Papillomaviruses
Like the PY capsid, the outer shell of Papillomaviruses (PV) is
composed of 360 molecules of the major capsid protein, L1 (Baker et
al., 1991). The structural information for HPV16 was derived from T=1
capsids composed of only 12 pentamers. The core capsomere is very
similar to the PY structure with eight β-strands contributing to the
antiparallel β-sandwich (Chen et al., 2000) (Figs.1A, B). The BC, DE, FG,
and HI surface loops are considerably larger. The larger size of L1 as
compared to VP1 explains size differences between the PY and PV
capsids (50 nm as compared to 60 nm, respectively). This structural
information suggested that the C-terminal arm folds back into the coree ﬁve-fold axis. Both images were reproduced with permission from (Chen et al., 2000).
402 Minireviewstructure from which it emanates leaving only helix 2, 3 and 4 for
pentamer–pentamer interactions via mainly hydrophobic bonds.
However, modeling based on the T=1 small VLP crystal structure
information (Chen et al., 2000) and electron cryomicroscopy image
reconstruction (Modis et al., 2002) suggests that C-terminal arms
invade neighboring capsomeres to form the principal interpentamer
contacts similar to PY (Fig. 1C). This model implies that a ﬂexible hinge
composed of residues 403 to 413 (HPV16 L1) bridges the gap between
capsomeres and is located at the base of the protein shell. Residues 419
to 429 form a α-helix (h4) that reaches halfway up the wall of the
invaded capsomere and brings Cys-428 in close contact with Cys-175
thus allowing disulﬁde formation (Modis et al., 2002). Disulﬁde bond
formation between these residues was conﬁrmed by mass spectro-
metry. In previous reports two groups had independently provided
evidence using a mutational approach that these cysteine residues are
involved in intercapsomeric disulﬁde bond formation (Li et al., 1998;
Sapp et al., 1998). The model further suggests that residues 430 to 446
extend around the circumference of the targeted capsomere. Residues
447 to 474 form the J β-strand and h5 helix that insert between two L1
molecules of the invaded capsomere and ﬁrmly link capsomeres.
Disulﬁde bond formation is not essential for virion formation but
strongly stabilizes virions and renders them resistant to nuclease and
protease treatment (Buck et al., 2005; Fligge et al., 2001). In this model
the majority of the C-terminal arm is surface-exposed, although
located within the intercapsomeric cleft, and thus may contribute to
the induction of neutralizing antibodies and may provide surfaces for
receptor binding. Indeed, binding sites of some neutralizing anti-
bodies have been mapped to the C-terminal arm (Carter et al., 2003).
However, the majority of neutralizing antibodies bind to conforma-
tional epitopes to which the surface loops BC, DE, FG, and HI
contribute (Carter et al., 2003; Ludmerer et al., 1996, 1997; Roth
et al., 2006; White et al., 1999).
Up to 72 molecules of the minor capsid protein, L2, are also found
in the viral capsid. Similar to PY VP2/3, L2 density was located at the
central internal cavity of each capsomere by cryo-EM but the majority
of the L2 chainwas not discernable (Buck et al., 2008). The observation
that L2 can occupy binding sites in adjacent capsomers raises the
possibility of homotypic L2 interactions. Biochemical evidence
suggests that L2 residues 396 to 439 (HPV11) mediate the interaction
with capsomeres probably via hydrophobic interactions (Finnen et al.,
2003). Another study found L2 residues 129 to 246 and 384 to 460
contained independent L1 interaction domains (BPV1) (Okun et al.,
2001). An N-terminal region of L2 (residues 60 to 120 of BPV1) has
been shown to be surface-exposed although this was not evident in
the cryo-EM reconstruction study, possibly due to relative structural
disorder (Kondo et al., 2007; Liu et al., 1997). Additional evidence
suggests that the extreme N-terminus folds back into the capsid thus
rendering it inaccessible to antibody binding and protease cleavage
(Richards et al., 2006; Yang et al., 2003). Since the central cavity of
capsomeres is not large enough to allow the passage of polypeptide
chains, it is likely that the L2 N-terminus extends to the capsid surface
between neighboring capsomeres, in line with observations that L2
protein stabilizes capsomere interactions under reducing conditions
(Sapp et al., 1995).
Receptors
Polyomaviruses
Polyoma- and papillomaviruses use various forms of carbohy-
drates as primary attachment receptors. Whereas JCV preferentially
utilizes α(2,6)-linked sialic acid attached to the serotonin 5-HT (2A)
receptor (Elphick et al., 2004; Komagome et al., 2002), SV40, BKV, and
PyV use gangliosides GM1, GD1b and GT1b, and GD1a and GT1b,
respectively (Low et al., 2006; Tsai et al., 2003). These are all branched
compounds which differ in length, composition and linkage of theside chains. BKV can also utilize N-linked glycoproteins with (α2,3)-
linked sialic acid (Dugan, Eash, and Atwood, 2005) and SV40 has been
shown to bind tomajor histocompatibility (MHC) class I antigen, but is
endocytosed independently (Anderson et al., 1998; Atwood and
Norkin, 1989; Breau et al., 1992). Structural analysis shows that GM1
binds to SV40 VP1 in a shallow groove formed by the BC-, DE-, and HI-
loops (Neu et al., 2008). Three VP1 molecules within a capsomere
contribute to the binding site and both arms of GM1 make contact
with VP1. The α-5-N-acetyl neuraminic acid (NeuNAc) arm interacts
with residues from the HI- and BC1-loops of one monomer (Pocket 1).
In addition, contacts were observed to the BC2-loop of the clockwise
neighbor. The Gal-(β1,3)-GalNAc arm contacts the HI- and BC2-loops
as well as the DE-loop of the counterclockwise neighboring VP1
molecule (Pocket 2). Individual binding afﬁnity is rather low with Kd
ranging between 1 and 5 mM, which is probably offset by the
presence of repetitive binding sites (Neu et al., 2008). It was recently
demonstrated that SV40 binds more strongly to a modiﬁed GM1
carrying a terminal glycolyl group (Campanero-Rhodes et al., 2007).
The modiﬁcation is found in simians whereas humans are unable to
synthesize this variant GM1. The available structure accommodates
the modiﬁcation and modeling predicts a higher afﬁnity correspond-
ing to the experimental results (Neu et al., 2008). The structure of PyV
with its oligosaccharide receptors GD1a and GT1b is not known. GD1a
and GT1b share a terminal (α2,3)-linked sialic acid (NeuNAc)). Instead
a Y-shaped hexasaccharide NeuNAc-1-(α2,3)-Gal-(β1,3)-[(α(2,6)-
NeuNAc-2]-Glc-NAc-(β1,3)-Gal-(β1,4)-Glc was used for crystallization
studies (Stehle and Harrison, 1997; Stehle et al., 1994). The
hexasaccharide shares the NeuNAc-1-(α2,3)-Gal-(β1,3) arm with
GD1a and GD1b, which yielded a well ordered structure in all ﬁve
monomers of the pentamer, whereas the second arm was less
ordered. The NeuNAc-1-(α2,3)-Gal-(β1,3) arm contacts residues in
the BC and HI loops. GD1b and GT1b, which serve as binding receptors
for BKV, share a terminal α2,8-linked NeuNAc, which is thus probably
the main contributor to interactions with the VP1 pentamer. No
structural information is available for BKV. The interaction of JCV VP1
with NeuNAc-(α2,6)-Gal-(β1,3)-GalNAc was modeled based on
structures of other PY viruses and mutational analysis of JCV VP1
and was predicted to involve residues in the BC-, DE-, and HI-loop
(Gee et al., 2004).
Papillomaviruses
Early work investigating the PV cell surface receptor found that PVs
bind to a widely expressed and evolutionarily conserved cell surface
receptor and that cell surface interaction depended primarily on L1
(Müller et al., 1995; Roden et al., 1994; Volpers et al., 1995). It was later
demonstrated by Joyce et al. that PV VLPs have a high binding afﬁnity
for glycosaminoglycans (GAGs), especially heparan sulfate (Joyce et al.,
1999). This study showed that HPV11 L1-only VLPs can interact with
immobilized heparin and soluble heparin could inhibit binding of
VLPs to HaCaTcells. Later work demonstrated that the interactionwith
cell surface HSPGs is critical for infection with HPV16 and HPV33
pseudovirions of COS-7 cells (Giroglou et al., 2001). This study also
suggested that, after binding to the HSPG, the capsids shift from a form
that is sensitive to competition by exogenous heparin to a form that is
resistant, suggestive of an interaction of the virion with a second
receptor molecule. Additional experiments have revealed potential
differences in the HSPG requirements among HPV types in vitro.
HPV31 was reported to not require HSPG interaction for keratinocyte
infection, but did interact with COS-7 in an HS-dependent manner
(Patterson et al., 2005). Neither heparin nor carrageenan, another
sulfated polysaccharide, was found to inhibit HPV5 infection (Buck
et al., 2006).
Heparan sulfate proteoglycan, HSPGs, are well described receptors
for growth factors, lipoproteins and numerous bacteria and viruses
(reviewed in Bernﬁeld et al., 1999). The two major families of cell
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et al., 1992; Fransson, 2003). HPV16 virus-like particle (VLP) binding
and HPV11 infection does not appear to require a speciﬁc HSPG
protein core for infection (Shafti-Keramat et al., 2003). Syndecan-1 is
the predominant HSPG in epithelial tissue and may serve as the
primary attachment receptor in vivo due to its high level of expression
in the appropriate target cell and upregulation during wound healing
(Bernﬁeld et al., 1992; Elenius et al., 1991; Gallo et al., 1994).
HSPG contain unbranched oligosaccharides composed of alternat-
ing disaccharide units of uronic acid and glucosamine, which are
sulfated and acetylated to various degrees. O-sulfation occurs at the 2-
O, 3-O, and 6-O position of the uronic acid and at the 3-O and 6-O
position of the amino sugar. The amino group of the glucosamine may
be either acetylated or sulfated. In vitro studies have shown that
infectious entry of PV requires N- as well as O-sulfation. However,
only O-sulfation is required for binding suggesting that distinct
interactions with HSPG may occur subsequent to cell interaction
(Selinka et al., 2003). This was recently conﬁrmed by the use of
heparan sulfate (HS) neutralizing reagents applied post attachment,
which efﬁciently blocked HPV infection without release of virions
from the cell surface (Selinka et al., 2007). The minimal length
requirement for HS binding is 8 monosaccharide units (Knappe et al.,
2007). However, it is likely that virion attachment to cells occurs via
polyvalent interactions as monovalent binding of HS molecules to
virions does not block infection (Bodevin et al., submitted for
publication). Primary attachment is mediated by positionally con-
served lysine residues (K278, K356, K361 for HPV16) located at the rim
of capsomeres. Modeling suggests that several L1 monomers of a
capsomere contribute to a single receptor binding site, ﬁve of which
are present per capsomere (Knappe et al., 2007). In this study, an
exchange of lysine residue 443, which is located at the vertex of
capsomeres, did not signiﬁcantly affect cell and HS binding but
strongly impaired infectivity of mutant virions, suggesting that
secondary binding events involve residues found in the cleft between
capsomeres. However, another study found that a neutralizing
monoclonal antibody that binds to an epitope in this intercapsomericFig. 2.Model of ECM and cell surface events following HPV16 infection. (1) HPV16 virions bin
cell surface. Capsids have also been shown to bind to ECM-resident laminin 5, however, thi
transferred to secondary HSPG binding sites present on the cell surface (HSPG2). Whether tra
been directly investigated. Interactionwith the HSPG2 cell surface receptor induces conforma
cleavage at a conserved cleavage site. Host cell cyclophilin B facilitates the conformation cha
reduces the afﬁnity of capsids to HSPG or result in exposure of sites required for handover to a
the binding site for the uptake receptor. Noninfectious internalization is observed in presencleft prevented cell surface association and consequently infection
(Day et al., 2007).
In vitro studies have shown that PV also bind to components of the
extracellular matrix (ECM) secreted by keratinocytes and can be
transferred from ECM to cells in an infectious manner (Fig. 2). Laminin
5 (LN5) as well as HS moieties are able to mediate binding to the ECM
(Culp et al., 2006a, 2006b; Selinka et al., 2007). However, infectious
transfer from the ECM seems to require HS binding (Selinka et al.,
2007), even though afﬁnity of virions is higher to LN5 than to HS (Culp
et al., 2006b). Importantly, infection can occur in the absence of ECM
binding, as evidenced by the permissiveness to HPV infection of cell
lines that secrete ECM lacking LN5, like e.g. COS-7 cells. The ECM
might function as the in vitro equivalent of the epithelial basement
membrane, which was recently identiﬁed as the primary site of virus
binding during genital tract infection in vivo (Roberts et al., 2007).
Studies using this murine cervicovaginal challenge model suggest that
virions bind initially to the basement membrane prior to transfer to
the basal keratinocyte cell surface. It has been possible to utilize this
model to investigate the HSPG dependency of HPV16, HPV31 and
HPV5 infection in vivo (Johnson et al., 2009). Through an examination
of both binding and infection of pseudovirions after heparinase
treatment it was found that HSPGs are the primary attachment factors
for all three of these virus types in vivo. However, HPV5 differed from
HPV16 and HPV31 in that infection could not be signiﬁcantly
prevented with heparin treatment despite having a demonstrable
interaction. The most likely explanation for this discrepancy is that
HPV5 has several distinct heparan sulfate binding sites, and that a site
that does not efﬁciently interact with soluble heparin mediates cell
surface attachment.
Accumulating evidence suggests that a secondary receptor is
involved in infectious internalization of PV particles subsequent to
HSPG interaction (Day et al., 2008; Selinka et al., 2007). A recent study
demonstrates that induction of a conformational change by pre-
cleavage of L2 within capsids with furin, further described below,
allows binding and infection in the absence of cell surface HSPG (Day
et al., 2008). The identity of this second binding moiety is stilld to primary attachment receptors, HSPG1, on ECM (basement membrane in vivo) or the
s interaction seems to be of lesser importance for productive infection. (2) Capsids are
nsfer from primary ECM binding sites to primary cell surface binding sites occur has not
tional changes resulting in the exposure of the L2 amino terminus and subsequent furin
nges. (3) These events seem to induce an additional conformational change that either
putative non-HSPG uptake receptor, which then triggers endocytosis. L1 likely provides
ce of furin and cyclophilin inhibitors.
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been suggested as secondary receptor (Culp et al., 2006b; Evander et
al., 1997; McMillan et al., 1999) but its involvement in HPV infection is
controversial and awaits further conﬁrmation (Giroglou et al., 2001;
Shafti-Keramat et al., 2003; Sibbet et al., 2000). As mentioned
previously, the cell surface interactions are predominantly L1-
dependent, although, possibly the L2 protein may contribute to
surface interactions. One of the regions of L2 that has been described
to mediate this appears not to be displayed on the virion surface in
solution. Because this region, residues 13 to 31 of HPV16 L2, is not
necessary for virion binding, it was proposed to interact with a cell
surface molecule after the virion has attached to a primary receptor
(Yang et al., 2003). This interpretation suggests that there is a
conformational change in the viral particle at the cell surface that
unmasks this domain of L2.
Attachment-induced conformational changes of capsid proteins
Polyomaviruses
Many viruses undergo conformational changes following cell
attachment to trigger downstream events including membrane
fusion, secondary receptor interactions and uncoating. Post-attach-
ment conformational changes have also been observed for both
polyoma- and papillomaviruses. One report suggested that PyV
capsids undergo conformational changes following interaction with
its oligosaccharide receptor (Cavaldesi et al., 2004), even though these
changes were not discernible in X-ray structures of capsids in
association with their carbohydrate receptors (Stehle and Harrison,
1996, 1997; Stehle et al., 1994). Cavaldesi showed that preincubation
with NeuNAc or NeuNGc increases cell binding and infectivity and
changes the protease sensitivity of capsid proteins. Similar changes
were observed after cell attachment. The exact nature of these
conformational rearrangements is unknown.
Papillomaviruses
For PVs, a conformational change is reﬂected in the described shift
from a heparin-sensitive to heparin-resistant form (Giroglou et al.,
2001). Supporting this are additional data from the same group which
describe the improved recognition of a neutralizing L1 epitope after
virion attachment to the cell surface (Selinka et al., 2003). Consistent
with this idea, L2 can induce cross-type neutralizing antibodies as a
free protein immunogen, but not when it is found in its typical
context, assembled in a PV capsid (Roden et al., 2000). This was
mechanistically explained by a later paper that showed L2 could be
cleaved by furin on the cell surface. This cleavage resulted in the
accessibility of the L2 cross-neutralization epitope (Day et al., 2008).
Therefore, L2-dependent neutralization must occur following these
events and not in solution. Furin cleaves the L2 protein at a consensus
cleavage site that is conserved among all papillomaviruses (Richards
et al., 2006). Proteolytic cleavage is essential for successful infection
and cannot be substituted by incorporation into virions of an N-
terminally truncated form of L2. This suggests that the N-terminus is
essential for L2 protein to adopt a correct conformation within the
assembled capsid.
It was also found that capsid interaction with HSPG results in a
conformational change that results in the exposure of the amino
terminal furin cleavage site. Following furin cleavage an additional
conformational change apparently exposes the binding site for the
secondary cell surface receptor, or it lowers the afﬁnity for the primary
receptor which results in the hand-off to the second receptor. It is
likely that this unidentiﬁed receptor is L1-speciﬁc, because trafﬁcking
of L1 VLPs, as examined by immunoﬂuorescence, is indistinguishable
from that of infectious virions through this stage (Day et al., 2003).
Additionally, L1/L2 capsids are internalized normally under conditionsof furin inhibition (Richards et al., 2006). However, it is possible that
subtly disparate pathways could appear microscopically similar.
Recent unpublished observations indicate that cell surface-asso-
ciated cyclophilin B (CyPB), a cellular petidyl–prolyl cis/trans
isomerase, may catalyze exposure of the furin cleavage site on the
cell surface. Inhibition of CyPB does not result in release of virions
from cells but induces their noninfectious internalization, suggesting
that it acts prior to or mediates the capsid protein rearrangements
which eventually result in reduced afﬁnity of virions to HS and the
subsequent transfer to the non-HSPG receptor (M. Bienkowska-Haba,
H. Patel, and M.S., manuscript submitted). Other reports have found
that inhibition of furin cleavage results in non-productive entry, but
inhibition of the conformational change allowing exposure of the furin
cleavage site results in retention of the virus on the cell surface (Day et
al., 2007, 2008). This is apparently the mechanism employed by the
dominant class of L1-speciﬁc neutralizing antibodies.
Taken together, these recent advances in our understanding of
early events of HPV infection suggest a dynamic model of virion–cell
surface interactions which has probably evolved to ensure the
inacessibility of critical regions. The remarkable conservation of the
requirement for L2 furin cleavage is suggestive that this elaborate
process evolved early in the speciation of papillomaviruses to prevent
a host antibody response to conserved virion epitopes that are
essential for infection. These sequences are inaccessible at the surface
of intact virions, but becomemore exposed by HSPG and cyclophilin B
interaction, and furin cleavage as detailed above.
Endocytosis
Polyomaviruses
Receptor usage determines the endocytic pathway taken by
polyomaviruses. As gangliosides accumulate in caveolae, SV40, PyV
or BKV enter cells via caveolar endocytosis (Eash et al., 2004; Gilbert
and Benjamin, 2004; Kartenbeck et al., 1989; Pelkmans et al., 2001). In
the case of SV40, this is associated with transient actin stress ﬁber
break down followed by renewed recruitment of actin to form actin
tails. Transient dynamin II recruitment and tyrosine kinase mediated
phosphorylation of caveolae-resident proteins accompanies this
process and are required for formation of caveolae and consequently
successful infection (Pelkmans et al., 2001). Inhibition of tyrosine
kinases blocks SV40 entry at the mouths of caveolae (Fig. 3) . BKV also
requires actin ﬁlament reorganization as the inhibitor jasplakinolide
interferes with successful infection (Eash and Atwood, 2005). In
contrast, JCV which utilizes serotonin receptors for binding is
internalized by clathrin-dependent endocytosis (Pho et al., 2000).
JCV also induces tyrosine kinase-mediated signaling, which is required
for virus entry (Querbes et al., 2004). However, unlike SV40 (Dangoria
et al., 1996) it additionally activates mitogen-activated protein kinases
ERK1 and ERK2 (Querbes et al., 2004).
Papillomaviruses
Neutralization experiments with cultured cells demonstrated an
extended period of susceptibility of infectious PV capsids to the
addition of neutralizing antibodies (Christensen et al., 1995; Culp and
Christensen, 2004). Other studies have demonstrated heparin neu-
tralization of HPV pseudovirus infection several hours following virion
addition (Giroglou et al., 2001; Smith et al., 2007). These data indicate
an unusually protracted residence on the cell surface for PVs. The
reason for the delayed kinetics observed for PVs is undetermined.
Possibly the conformational changes described previously are slow
events. Alternatively, the secondary receptor could be sparsely arrayed
or exhibit particular requirements for endocytosis.
In vitro experiments show that following associationwith a cellular
receptor, this receptor must bind to F-actin in order to be pulled by
Fig. 3. Endocytosis of polyomaviruses. SV40 and BK viruses which apparently utilize the same endocytic route are indicated in green. They are endocytosed, possibly via transfer from
lipid rafts, into caveolae. Caveolar + pinocytic vesicles deliver the virions into the caveosome. They are then transported into the endoplasmic reticulum via caveolin-free, COP1+
vesicles. Murine polyomavirus, indicated in blue, can be transported from lipid rafts into caveolin-positive monocytic vesicles. These vesicles fuse with early endosomes and the virus
is then transported into caveosomes and subsequently into the ER. Direct fusion of monocytic vesicles with the ER has also been demonstrated to deliver PyV virions. JC virus,
indicated in red, is internalized in clathrin coated vesicles (CCV) and transported through early endosomes en route to the caveosome. It is then delivered into the ER via a route
similar to SV40 and BK.
405Minireviewactin retrograde ﬂow towards the cell body (Schelhaas et al., 2008).
This requirement may contribute to prolonged residence on the cell
surface. Additionally, infection seems to be highly asynchronous as
highly sensitive nested RT-PCR techniques detected early viral
transcripts as early as 2 h post-binding for BPV-4 (Sibbet et al.,
2000), 4 h for HPV31 (Patterson et al., 2005) and 12 h for BPV-1 (Day et
al., 2003). Since more quantitative techniques show a gradual increase
in the number of viral transcripts in the 2–4 days following infection in
most susceptible cell lines (Culp and Christensen, 2004), it appears
that the intracellular events leading to a virus establishment are also
proceeding slowly.
The mechanisms by which PVs are endocytosed are still unclear
and these studies have yielded little concordance. An early study that
analyzed BPV1 entry concluded that this virus utilizes a clathrin-
dependent endocytic pathway for infectious uptake, albeit with
atypical kinetics (Day et al., 2003). This study utilized a combination
of microscopic analyses and biochemical inhibition of described
pathways. Colocalization of particles was found with AP-2, a clathrin
adaptor molecule, transferrin receptor, which trafﬁcs through the
early endosomes and lamp 2, a late endosomal/lysosomal marker.
Inhibitors which blocked infection included chlorpromazine, baﬁlo-
mycin A, latrunculin B, nocodozole and ammonium chloride. Clathrin-
dependent endocytosis of BPV1 was recently conﬁrmed using
pseudovirions based on the sensitivity to chlorpromazine and initial
colocalization of virions with the early endosomal antigen (EEA-1)
(Laniosz et al., 2008). Chlorpromazine sensitivity was also reported for
HPV16 pseudovirions (Smith et al., 2007). Selinka et al. examined a set
of biochemical inhibitors for effects on HPV-33 pseudovirus infection
and found a dependence upon an intact actin cytoskeleton and
microtubules (Selinka et al., 2002). In contrast to these studies, Spoden
et al. observed clathrin- and caveolae-independent internalization of
HPV16 pseudovirions in HeLa and HEK 293TTcells. Entry occurred by a
mechanism that was resistant to combined siRNA-mediated down
regulation of caveolin-1 and clathrin heavy chain as well as resistant
to over-expression of dominant negative mutants of caveolin-1 and
eps-15 (EGF receptor pathway substrate clone No. 15, which plays arole in clathrin coated vesicle formation) (Spoden et al., 2008). These
authors suggested that tetraspanin-enriched microdomains serve as
platforms for internalization by an uncharacterized internalization
pathway. None of these studies could demonstrate an effect of
caveolae disruption on infection, via nystatin or ﬁlipin treatment on
HPV16 infection.
An early study utilizing infectious VLP–DNA complexes found
unexpectedly that HPV-31 transduction, but not transduction by VLPs
of several other HPV types, was inhibited by nystatin, a caveolae
inhibitor (Bousarghin et al., 2003). This result was conﬁrmed and
expanded upon by the Ozbun group. They described the caveolar
uptake of HPV31 virions in keratinocytes (Smith et al., 2007).
However, one study found that biochemical inhibition of clathrin-
dependent uptake did prevent HPV31 infection (Hindmarsh and
Laimins, 2007). As previously mentioned HPV31 appears to interact
with HSPG similarly to HPV16 for in vivo infection. Possibly HPV31
interacts differently with or has a unique co-receptor that shunts it
into a different internalization pathway. There is precedence for
closely related naked icosahedral viruses using distinct uptake
pathways, as noted for polyomaviruses.
Intracellular trafﬁcking and uncoating
Polyomaviruses
In general the complexities of vesicular trafﬁcking are still not well
understood, and the variousmechanisms by which viruses exploit this
system are even more unclear. There are a number of instances in
which viral trafﬁcking does not conform to the established kinetics of
known endocytic pathways. In addition, an increasing number of
reports describe a “cross-talk” amongst the diverse internalization
pathways (Pelkmans et al., 2004). As more dominant-negative
versions and validated siRNAs become available for genes involved
in intracellular membrane trafﬁcking, the dependence upon biochem-
ical inhibition is lessened and this may allow for more speciﬁc
interference of the various pathways.
406 MinireviewOnce caveolin-1 containing endocytic vesicles have budded from
caveolae, SV40 virions accumulate in peripheral organelles, named
caveosomes, which do not containmarkers for endosomes, lysosomes,
ER or Golgi (Pelkmans et al., 2001). Caveosomes were ﬁrst discovered
using SV40 but are preexisting, intracellular, non-acidic organelles to
which caveolin-containing but not clathrin-coated endocytic vesicles
are targeted. From here SV40 is sorted into tubular caveolin-free
vesicles (Pelkmans et al., 2001), which are transported in a micro-
tubule-dependent manner to the endoplasmic reticulum (ER) via an
intermediate compartment that contains β-COP and is sensitive to
brefeldin A (Norkin et al., 2002; Richards et al., 2002). These data
suggest that COPI vesicles mediate the retrograde transport of SV40
from caveosomes to the ER. As lipid binding sites for SV40 are present
in rough ER membranes it seems likely that the virus is bound to its
ganglioside receptor throughout the transfer from the plasma
membrane to the ER (Tsai et al., 2003). BKV has also been suggested
to trafﬁc through the ER similar to SV40 (Gilbert and Benjamin, 2004;
Gilbert et al., 2003; Low et al., 2006; Tsai et al., 2003). In contrast,
caveolae-derived pinocytic vesicles containing PyV were shown to
fuse with the early endosomes. Virus was then delivered into the
caveosome with subsequent delivery into the ER. However, in the
absence of functional caveolae PyV can be internalized via a non-
caveolae, non-clathrin pathway that also targets the ER suggesting a
cross-talk between clathrin- and caveolae-dependent endocytosis
(Liebl et al., 2006). A cross-talk between these internalization
pathways has also been reported for JCV (Querbes et al., 2006). After
clathrin- and eps15-dependent endocytosis and transport to early
endosomes (Querbes et al., 2004), JCV is sorted to caveosomes in a
Rab5-GTPase-, cholesterol-, caveolin-1-, and pH-dependent manner.
Similar to SV40, JCV is further transported from caveosomes to ER via a
brefeldin A-sensitive pathway suggesting the involvement of ARF1
GTPase and COPI vesicles (Querbes et al., 2006).
After endocytic uptake, access of most ligands to the cytosol is
limited and tightly regulated. Nonenveloped viruses either lyse the
limiting vesicular membrane or generate a pore through it, which
requires conformational change of the capsid or uncoating to expose
hydrophobic domains. Uncoating of SV40 is ﬁrst observed in the ER by
immunoﬂuorescent detection of minor capsid proteins VP2 and VP3,
which are inaccessible to antibody binding in intact virions (Norkin et
al., 2002). Several ER-resident proteins are required for virion
disassembly and transport of the viral genome across the ER
membrane into the cytosol. It is unclear at present if the membrane
is crossed by partially disassembled virions or if only the genome is
translocated into the cytoplasm or even directly into the nucleus thus
bypassing nuclear pores. It seems clear, however, that different
polyomaviruses may have evolved different mechanisms to escape
the ER.
SV40 requires the activity of two thiol–disulﬁde oxidoreductases,
ERp57 and PDI, to complete infection. ERp57 converts C9–C9
intrachain disulﬁde bonds to C9–C104 interchain disulﬁdes (Schelhaas
et al., 2007). This requires a reduced C104 residue in close contact to
the C9–C9 disulﬁde bond that is likely only available at the three-fold
axis linking pentavalent with hexavalent capsomeres (Stehle et al.,
1996). Isomerization results in the uncoupling of twelve of the 72
pentamers, which are released from the virion at low Ca2+. It seems
likely that the pentavalently organized pentamers are affected and
that it requires the low Ca2+ environment of the cytosol (Schelhaas et
al., 2007). ERp57 is not essential for infection of C9–C104 mutant
viruses conﬁrming that it isomerizes disulﬁde bonds formed by these
two cysteine residues. In addition to ERp57 and PDI, Derlin-1 and
Sel1L, members of the ER-associated degradation (ERAD) pathway, are
essential for completion of SV40 infection. It was therefore suggested
that SV40 virions that have undergone disulﬁde isomerization utilize
the translocation machinery used for misfolded ER components to
escape from the ER into the cytosol. It seems likely that in addition to
these cellular factors, VP2/VP3 contribute to ER escape. Both havebeen shown to associate with and destabilize membranes. This
propensity of VP2/VP3 seems to be regulated by interaction with
VP1 (Daniels et al., 2006a, 2006b).
Another component of the ERAD pathway, Derlin-2, has been
shown to be essential for PyV infection. Similar to ERAD components
essential for SV40 infection, its activity is required in the ER. Derlin-2
can be bypassed by introducing viral DNA into the cytosol, suggesting
that it mediates the passage of virions across the ER membrane (Lilley
et al., 2006). Similar to SV40, PyV VP2/VP3 associate with cellular
membranes (Delos et al., 1993). Exposure of the minor capsid proteins
is catalyzed by the ER-resident chaperone ERp29 (Magnuson et al.,
2005). ERp29 induces a conformational change in PyV particles
affecting the C-terminus of VP1 without inducing complete disin-
tegration of the virion structure. The change results in the association
of virions with ER membranes. Portions of VP2 are exposed, which
mediate binding to ER membranes. VP2 then integrates into and
perforates model membranes. Although VP3 can also bind and
integrate into membranes it cannot perforate them (Rainey-Barger
et al., 2007). PyVmay not require disulﬁde isomerization of VP1 as it is
not extensively disulﬁde cross-linked (Schelhaas et al., 2007).
Papillomaviruses
Given the divergent reports regarding the endocytic mechanisms
utilized by PV, it is unsurprising that the subject of intracellular
trafﬁcking of PV-containing vesicles and the cellular compartments
involved is also highly controversial. There is near consensus that
successful infection requires acidiﬁcation of endocytic vesicles
suggesting that PV particles must pass through the endosomal
compartment (Day et al., 2003; Selinka et al., 2002; Smith et al.,
2008; Spoden et al., 2008). Colocalization with early endosome
markers has been observed for BPV1 (Day, Lowy, and Schiller, 2003;
Laniosz et al., 2008), but not for HPV16 pseudovirions (Spoden et al.,
2008). HPV31 particles were found to enter via caveolae, be
transported to caveosomes, and then to early endosomes in a Rab5
GTPase- and pH-dependent manner (Smith et al., 2008). Since the
infection did not require functional Rab7, it was suggested that
infectious genomes exit the endocytic pathway prior to transit into the
late endosomes. In contrast, the Meneses lab reported initial entry of
BPV1 via a clathrin-dependent pathway and subsequent delivery from
the early endosome into the caveosome with later entry into the ER.
Over-expression of a caveolin-1 dominant-negative protein prevented
infection without affecting the initial internalization (Laniosz et al.,
2008). However, other work has shown that the BPV1 genome
accumulates in late endosomes or lysosomes if egress from the
endocytic compartment to the cytosol is blocked (Kämper et al., 2006).
The advent of siRNA-mediated gene knockdown and dominant-
negative constructs targeting multiple endocytic mediators has
allowed more scrutiny of the PV uptake pathways. Unfortunately at
this juncture there is no concordance on any issue. The studies are
complicated by the fact that different laboratories are utilizing
different virus sources. In early studies pseudovirions were used
prior to the appreciation of virion maturation. Immature viruses may
enter by different mechanisms or would at least exhibit an altered
conformation. Different cell lines have also been examined. It is
reasonable to assume that cultured cell lines from disparate lineages
have different “dominant” endocytic pathways. Therefore, the same
cargo could utilize a different route. Another issue is that inhibition of
these pathways is usually evaluated by observing the entry of small,
physiological cargoes, i.e. transferrin, whereas in the experimental
conditions we are evaluating the entry of a large, multivalent virus.
Another problem is that inhibition of one endocytic pathway often
results in a compensatory upregulation of a different pathway. This
cellular effect can obfuscate the interpretation if the virus can utilize
two different modes of entry, as has been shown for SV40 (Damm et
al., 2005). It has long been accepted that SV40 enters via caveolae.
Further reading
Please see the manuscript entitled “The Polyomaviridae: Contributions of virus struc-
ture to our understanding of virus receptors and infectious entry” in this issue,
which also describes polyoma virus structure and entry.
407MinireviewHowever, this study showed that SV40 can productively enter and
infect caveolin-deﬁcient cells. There has also been a newfound
appreciation for the interaction between entry pathways that were
formerly considered to function separately. It is likely that further
experimentation will result in more understanding of PV entry and
might lead to the discovery of entirely new entry pathways altogether.
At this point a comprehensive study of intracellular trafﬁcking by
different PV types in parallel in normal keratinocytes is still lacking. Of
most interest would be the development of a system for evaluation of
selective in vivo inhibition of the various pathways. However that
would pose a new set of technical hurdles.
Two assays have been described to examine the uncoating of
papillomaviral pseudoviruses. They were developed in tandem to
detect exposure of either an interior region of L2 or the BrdU-labeled
viral pseudogenome (Day et al., 2004). Examination of when these
determinants became accessible to antibody staining suggested that
uncoating occurs in endocytic vesicles prior to transfer to the cytosol.
That disassembly of the viral particle must occur before nuclear
import was suggested by previous reports showing that intact HPV
capsids exceed the size capacity for transit across the central NPC
channel (Merle et al., 1999; Nelson et al., 2000).
It has been shown that the minor capsid protein, L2, allows escape
of the viral genome from the endosome (Kämper et al., 2006). L2 was
found not to be required for viral uncoating but was necessary for
egress from the endocytic pathway. A short, hydrophobic peptide
derived from the carboxyl terminus of HPV-33 L2 harbors membrane
disrupting capacity. If this region is deleted the resultant pseudovirus
is unable to establish infection, despite unaffected DNA encapsidation
and cell surface interactions. Microscopic analysis of non-infectious
capsids containing a similar deletion in BPV-1 L2 shows that the
mutant L2 protein and the viral genome are retained together within
the endosomal compartment at late timepoints post-infection.
The issue of how the papillomaviral genome transits from the
endosome to the nucleus has not been systematically addressed.
Although furin cleavage of L2 occurs at the cell surface we believe that
the functional effect is later in entry. Furin cleavage of L2 could enable
the release of the L2-genome complex from L1, because L1 does not
appear to exit from the endosomal compartment. Another possibility
is that it could promote L2 binding to a speciﬁc receptor. It is intriguing
that a binding site for syntaxin-18 was mapped to a peptide
immediately downstream of the cleavage site. It was found to bind
to L2 residues 40 to 44 of BPV1 and a syntaxin-18 dominant negative
blocked infection (Bossis et al., 2005; Laniosz et al., 2007). However,
the mechanism or consequence of this interaction has not yet been
fully elucidated. Syntaxin 18 is an ER-resident protein. To date there
has been no convincing ER localization of PV during infectious entry.
Other data support co-delivery of L2 and genome to the nucleus for
HPV16 and BPV1 L2, perhaps in conjunction with a cell-encoded
chaperone (Florin et al., 2006).
The microtubule disrupting drug nocodazole inhibits PV infection
at a late step in infection (Day et al., 2003; Selinka et al., 2002). It is
well established that vesicle trafﬁcking occurs along microtubules.
However, microtubule-dependent transport may also be required for
the post-endosomal step of delivering the viral genome into the
nucleus. Cytoplasmic transport along microtubules is mediated by
motor protein complexes that use cellular energy to move cargo. The
L2 protein of HPV16 and HPV33 was found to interact with the
microtubule network via the motor protein dynein during infectious
entry (Florin et al., 2006). The C terminal 40 amino acids of L2 were
found to be essential for interaction with the dynein complex.
It was shown that L2 and the viral genome colocalized in the
nucleus at ND10 domains (PML nuclear bodies) (Day et al., 2004)
following infection suggesting that they are translocated to the nucleus
as complex. Cytoplasmic microinjection of L2-speciﬁc antibodies
blocks infection conﬁrming their continued association in the cytosol
(M. Bienkowska-Haba, L. Hilbig, and M.S., unpublished observations).Whether nuclear translocation is mediated by nuclear localization
signals provided by L2 as previously suggested (Bordeaux et al., 2006;
Fay et al., 2004) or by other means awaits further investigations. L1
protein is not detectable in the nucleus, which may be due to its
complete shedding during uncoating as it has been shown to
accumulate in Lamp/CD63-positive vesicles, which could be late
endosomes or multivesicular bodies (Spoden et al., 2008). The
localization of the genome and L2 at ND10 is critical for the
establishment of infection in that efﬁcient early PV transcription
required either intact ND10 or expression of the PMLprotein (Dayet al.,
2004).
Summary
The tasks of a successful virus include ﬁnding and recognizing a
suitable cell in which it can replicate. This necessitates receptor
engagement, endocytosis, release of the genome, generation of new
viral components, and assembly and release of progeny virions. This
review has focused on the structure of the newly assembled particles
and the early steps in their transmission to the host cell. Polyoma- and
papillomaviruses have evolved different mechanisms for delivery of
their DNA, but there must be relatedness to the structures which
accomplish this as the overall similarity of their capsids is a reﬂection
of the fundamental processes following. The stable virion must
necessarily become unstable upon interaction with the host cell
leading to eventual release of the genome in the correct cellular
environment that ensures expression of its genome. The relationship
between the structure and these processes cannot be overlooked.
Understanding the mechanisms by which the virion achieves
controlled lability may clear the path to better understanding of the
concurrent endocytic events. Appreciation of the host cell that is the
vessel for these processes is also critical. Utilization of cells across
lineages and transformation states may yield disparate results.
Biochemical and genetic inhibitors, although necessary tools for
these studies, must be employed with the perception of the resultant
cellular effects. With these cautions we anticipate exciting strides to
be made in these ﬁelds.
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